Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesCatabolism of lipoproteins and metabolic syndrome
Current Opinion in Clinical Nutrition & Metabolic Care, 06/17/09
Therond P - Dyslipidemia plays an important role in the development of atherosclerosis and is mainly associated by the hepatic overproduction of large triglyceride-rich VLDL, low levels of HDL cholesterol and high levels of small, dense, LDL cholesterol particles. It is thus of special interest to understand the mechanism involved in the hepatic synthesis of lipoproteins and the degradation of these lipoproteins that depend, to a large extent, on insulin action. The atherogenic lipid abnormalities observed in the metabolic syndrome may require a combination of drugs such as statins and HDL-raising agents to provide a more complete approach to treating dyslipidemia and reducing cardiovascular risk.
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Atorvastatin Inhibits gp91phox Circulating Levels in Patients With Hypercholesterolemia
Arteriosclerosis, Thrombosis, and Vascular Biology, 12/17/09
Peroxisome Proliferator-Activated Receptor-gamma Coactivator 1-alpha Overexpression Prevents Endothelial Apoptosis by Increasing ATP/ADP Translocase Activity
Arteriosclerosis, Thrombosis, and Vascular Biology, 12/16/09
Adiponectin, cardiac geometry and function in elderly: results from two community-based cohort studies
European Journal of Endocrinology, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor